Aardvark released exploratory data from its stopped Phase 3 HERO trial in Prader-Willi syndrome after FDA lifted the hold, and plans a redesigned Phase 3.
|Articles|February 9, 2018
Bio-Optronics Announces Advanced Business Intelligence Reporting for CTMS
Advertisement
February 9, 2018-ROCHESTER, NY-Bio-Optronics, the makers of the market-leading Clinical Conductor clinical trial management system (CTMS) announces the release of an advanced business intelligence (BI) reporting module designed to provide health systems, CROs and other research organizations real-time access to analytics that drive decisions and business growth.
The BI reporting tool, available as a module in Clinical Conductor CTMS, allows users to quickly create recurring and ad-hoc reports that produce clear insights and identify trends that empower business leaders to make confident decisions that positively impact all levels of the research business.
“Clinical research business leaders are expressing a clear need for a tool that quickly and easily organizes their enormous quantities of data into something actionable,” says Kate Yawman, Product Line Manager for Clinical Conductor CTMS. “With just a few clicks, our BI module provides access to the information our users need to run the world’s best research.”
The business intelligence reporting module is available now for users of Clinical Conductor CTMS. Bio-Optronics will be debuting the BI Module at 9th Annual SCOPE Summit, taking place February 12-15, 2018 in Orlando, FL. The Clinical Conductor CTMS team will also be exhibiting at the 12th Annual Clinical Trial Billing and Research Compliance Conference in Orlando, FL from February 26th-27th, and at the 4th European Conference on Clinical Research in Vienna, Austria.
About Bio-Optronics
Bio-Optronics is a leading software and services company that creates user-focused applications for healthcare organizations that positively impact business performance. With applications focused on clinical research, automated resource utilization and patient safety, Bio- Optronics software is used by thousands of healthcare organizations worldwide to simplify complex business processes and enhance overall quality and efficiency.
For more information, visit www.bio-optronics.com or follow @BioOptronics on Twitter or LinkedIn.
Advertisement
Related to this article
Clinical trials capture data faster than ever, but the real bottleneck is the distance between data capture and a decision teams can trust.
In today’s ACT Brief, we examine why the future of AI in trials is a trusted orchestration system rather than a single model, how coordinators rate eSource-enabled workflows, and what a bipartisan bill proposes for reusable trial networks.
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
2
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
3
Bipartisan Bill Would Build Reusable Clinical Trial Networks, With a Focus on Rare Disease
4
Where AI Governance in Clinical Development Falls Short
5